{"data":{"id":"us/21-cfr-640.10","jurisdiction":"us","citation":"21 CFR 640.10","heading":"Red Blood Cells.","body":"The proper name of this product shall be Red Blood Cells. The product is defined as red blood cells remaining after separating plasma from human blood.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER F—BIOLOGICS","PART 640—ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS","Subpart B—Red Blood Cells"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"c15767380a9d0efba6311c4bbe52f3eb90a8fe50838db84a0aea19be2bbf9e76","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-640.6","next":"us/21-cfr-640.11"},"notice":"GroundRules: Original legal text. Not legal advice."}